logo
NASA scientists describe ‘absolute sh*tshow' at agency as Trump budget seeks to dismantle top US climate lab

NASA scientists describe ‘absolute sh*tshow' at agency as Trump budget seeks to dismantle top US climate lab

CNN05-06-2025
Federal agencies
Space programs
Climate changeFacebookTweetLink
Follow
NASA scientists are in a state of anxious limbo after the Trump administration proposed a budget that would eliminate one of the United States' top climate labs – the NASA Goddard Institute for Space Studies, or GISS – as a standalone entity.
In its place, it would move some of the lab's functions into a broader environmental modeling effort across the agency.
Career specialists are now working remotely, awaiting details and even more unsure about their future at the lab after they were kicked out of their longtime home in New York City last week. Closing the lab for good could jeopardize its value and the country's leadership role in global climate science, sources say.
'It's an absolute sh*tshow,' one GISS scientist said under condition of anonymity because they were not authorized to speak to the media. 'Morale at GISS has never been lower, and it feels for all of us that we are being abandoned by NASA leadership.'
'We are supposedly going to be integrated into this new virtual NASA modeling institute, but (we have) no idea what that will actually look like,' they said.
NASA is defending its budget proposal, with a nod toward the lab's future.
'NASA's GISS has a significant place in the history of space science and its work is critical for the Earth Science Division, particularly as the division looks to the future of its modeling work and capabilities,' NASA spokesperson Cheryl Warner said in a statement.
'Fundamental contributions in research and applications from GISS directly impact daily life by showing the Earth system connections that impact the air we breathe, our health, the food we grow, and the cities we live in,' Warner said.
GISS has a storied history in climate science on the global scale.
James Hansen, a former director, first called national attention to human-caused global warming at a Senate hearing during the hot summer of 1988. The lab, founded in 1961, is still known worldwide for its computer modeling of the planet that enable scientists to make projections for how climate change may affect global temperatures, precipitation, extreme weather events and other variables.
The about 125 scientists who work there are also known for tracking global temperatures, with GISS' records serving as one of the independent checks on other labs around the world monitoring global warming.
The lab stands out, the scientist said, for its 'fundamental work contributing to our understanding of global warming, volcanic and aerosol forcing of climate, and advances in detection and attribution' of climate change impacts.
'All work that was curiosity-driven and enabled by the autonomy we had at GISS to pursue these questions,' they said, adding: 'Everyone is stressed because we have no clarity from leadership on even what the long-term plan is. (It) Really feels like we are just being left to die on the vine.'
Another GISS scientist, who also spoke under the condition of anonymity, said the lab's independence has been key to its success, which can be seen in the abundance of published studies from researchers at the facility.
The autonomy afforded to GISS over the years, given its distance from NASA headquarters in Washington, and its academic-like freedom helped its researchers take on important studies that might not be pursued in other circumstances, they said.
And unlike high-level managers at NASA, GISS' leadership received high marks for their communications and advocacy of the center's work, according to three researchers.
'It is important for climate modeling to continue,' one of the GISS researchers said. 'They're the best tools that we have for the planet.'
A technical NASA budget supplement released late last week committed to 'strengthening America's leadership in space exploration while exercising fiscal responsibility. NASA is adapting the way we work and invest to accomplish our mission,' Warner, the spokesperson, said.
That Republicans' proposed NASA budget includes funding for climate modeling at all is notable, considering its cuts for space exploration and overall Earth science. Numerous space exploration missions and satellites would be abandoned under the budget, including some satellites already in space that are actively sending climate-related data back to Earth.
The budget supplement makes GISS' fate both clear and hazy. It states Earth system modeling activities at four different NASA centers will be merged into one 'virtual institute.' This would incorporate 'core capabilities' of GISS 'as needed,' it adds.
'GISS as an independent entity will not continue,' the document says.
This fate may be considerably better for NASA's climate scientists than the worst-case scenario seen at agencies like the National Oceanic and Atmospheric Administration, where the budget for nearly its entire weather and climate research portfolio would be zeroed out and most of its research labs shuttered.
Overall, the NASA budget would be a 24% cut compared to last year, with a 47% cut to agency science activities, according to The Planetary Society, a group that advances space science and innovation.
Its analysis found the NASA funding level would be the smallest since 1961 when adjusted for inflation.
The ultimate decisions on the future of climate modeling at NASA, as well as its space exploration activities, will fall to Congress as members consider the budget proposal, adding even more uncertainty to an already fraught period for GISS's staff.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula

Yahoo

time20 minutes ago

  • Yahoo

Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula

Novel preservative-free CBT-004 eye drop formulation demonstrates statistically significant improvements in conjunctival hyperemia and patient-reported symptoms with excellent safety profile IRVINE, Calif., July 21, 2025--(BUSINESS WIRE)--Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evaluating CBT-004 ophthalmic solution in patients with vascularized pinguecula and associated conjunctival hyperemia. Key Phase 2 Results Primary Endpoint Achieved: Both investigated concentrations of CBT-004 demonstrated statistically significant improvements in conjunctival hyperemia compared to vehicle at Day 28, as assessed by an independent reading center using digital imaging. Rapid Onset and Sustained Efficacy: Significant improvements were observed as early as Day 7 with the highest investigated concentration CBT-004 , with benefits persisting through the 28-day treatment period. Significant Symptom Relief: Both CBT-004 concentrations showed statistically significant improvements in five common patient-reported symptoms including burning/stinging, itching, foreign body sensation, eye discomfort, and pain compared to vehicle. Excellent Safety Profile: No treatment-related adverse events were observed. Most adverse events were mild to moderate. No clinically meaningful changes in visual acuity or intraocular pressure were reported. Addressing a Significant Unmet Medical Need Vascularized pinguecula affects millions of Americans and represents a substantial unmet medical need in ophthalmology. This common, benign conjunctival growth can become problematic when it develops abnormal blood vessels and inflammation, which can lead to persistent redness, irritation, pain, and foreign body sensation. Current management options are limited, with many patients relying on off-label corticosteroids or surgical excision, both of which carry significant limitations and potential complications. Study Design and Results The multicenter, randomized, double-masked, vehicle-controlled Phase 2 study enrolled 88 adult patients with vascularized pinguecula and associated conjunctival hyperemia. Participants were randomized to receive one of two concentrations of CBT-004, or vehicle. The primary endpoint was the change from baseline in conjunctival hyperemia at Day 28, as measured by an independent reading center using standardized digital imaging protocols. Expert Commentary "There is a significant unmet need for patients suffering from symptomatic pinguecula, as current therapies are largely off-label and may carry safety concerns with long-term use," said Dr. John Hovanesian, Clinical Professor of Ophthalmology and recognized key opinion leader in anterior segment disease. "The results from this trial are exciting, as they demonstrate that a targeted, non- steroidal therapy can meaningfully improve both the clinical signs and symptoms that impact patients' quality of life." "As a principal investigator in this study, I was impressed by the consistency and magnitude of improvement in both objective redness and patient-reported discomfort with CBT-004," commented Dr. Sherif El-Harazi, Medical Director at Global Research Management. "The safety profile was excellent, and I believe this therapy could represent a meaningful advance for our patients with vascularized pinguecula." About CBT-004 CBT-004 is a novel, preservative-free topical ophthalmic solution containing a potent and selective inhibitor of vascular endothelial growth factor (VEGF) receptors and platelet-derived growth factor (PDGF) receptors. The formulation is specifically designed to reduce abnormal blood vessel growth and inflammation associated with vascularized pinguecula while minimizing potential ocular surface toxicity through its preservative- free composition. Next Steps and Regulatory Strategy Based on these positive Phase 2 results, Cloudbreak Pharma Inc. plans to advance CBT-004 into Phase 3 development and initiate discussions with the U.S. Food and Drug Administration (FDA) to establish the regulatory pathway toward potential approval. The company anticipates providing updates on Phase 3 study design and timing in the coming months. Market Opportunity The vascularized pinguecula market represents a significant commercial opportunity with limited therapeutic options. The prevalence of pinguecula increases with age and UV exposure, affecting a substantial portion of the aging population. With no FDA-approved treatments specifically indicated for this condition, CBT-004 has the potential to become a category-defining therapy in this underserved market. About Cloudbreak Pharma Inc. Cloudbreak Pharma Inc. is a clinical-stage ophthalmology company dedicated to developing innovative therapies for ocular surface diseases with high unmet medical need. The company's pipeline focuses on novel treatments targeting inflammation, vascularization, and other pathological processes affecting the ocular surface. Cloudbreak is committed to improving outcomes for patients with challenging eye conditions through scientifically-driven therapeutic development. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the potential therapeutic benefits of CBT-004, the company's clinical development plans, regulatory strategy, and market opportunity. These forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could cause actual results to differ include, but are not limited to, the uncertainty of clinical trial results, regulatory approval processes, competitive developments, and other risks detailed in the company's filings. The company undertakes no obligation to update these forward-looking statements except as required by law. Please note that the information contained in this press release may not be complete. For further details about Cloudbreak Pharma Inc., and our drug candidates, please refer to our company's website (at View source version on Contacts Contact Information: Cloudbreak Pharma media@ Web: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Trump news at a glance: president goes on offensive over NFL and MBL team names
Trump news at a glance: president goes on offensive over NFL and MBL team names

Yahoo

time20 minutes ago

  • Yahoo

Trump news at a glance: president goes on offensive over NFL and MBL team names

Donald Trump has weighed into a new fight – this time with two sports teams. The president wants Washington's football franchise the Commanders and Cleveland baseball team the Guardians to revert to their former names, which were abandoned in recent years due to being racially insensitive to Native Americans. Trump said on Sunday on Truth Social that: 'The Washington 'Whatever's' should IMMEDIATELY change their name back to the Washington Redskins Football Team …. Likewise, the Cleveland Indians, one of the six original baseball teams, with a storied past.' Josh Harris, whose group bought the Commanders in 2023, said earlier this year the name was here to stay. The Guardians' president of baseball operations, Chris Antonetti, indicated before Sunday's game against the Athletics that there weren't any plans to revisit the name change. Trump demands Guardians and Commanders change names Donald Trump has said that he would move to block the Commanders' plans to build a new stadium at the old RFK Stadium site in Washington DC unless they changed their name. It is unclear if Trump would be able to do so. The RFK Stadium site was once on federal land but Joe Biden signed a bill earlier this year – one of his final acts in office – transferring control to the DC city government for a 99-year term. Trump also posted that the call to change names applied to Cleveland's baseball team, which he called 'one of the six original baseball teams'. Read the full story Ice secretly deports man, 82, from Pennsylvania An 82-year-old man in Pennsylvania was secretly deported to Guatemala after visiting an immigration office last month to replace his lost green card, according to his family, who have not heard from him since and were initially told he was dead. According to Morning Call, which first reported the story, longtime Allentown resident Luis Leon – who was granted political asylum in the US in 1987 after being tortured under the regime of the Chilean dictator Augusto Pinochet – lost his wallet containing the physical card that confirmed his legal residency. He and his wife booked an appointment to get it replaced and when he arrived at the office on 20 June he was handcuffed by two Immigration and Customs Enforcement (Ice) officers, who led him away from his wife without explanation, she said. The family said they made efforts to find any information on his whereabouts but learned nothing. Read the full story Ice chief says he will continue to allow agents to wear masks The head of US Immigration and Customs Enforcement (Ice) said on Sunday he would keep allowing the controversial practice of his officers wearing masks over their faces during their arrest raids. As Trump has ramped up his unprecedented effort to deport immigrants around the country, Ice officers have become notorious for wearing masks to approach and detain people, often with force. Legal advocates and attorneys general have argued that it poses accountability issues and contributes to a climate of fear. Read the full story US scientists describe impact of Trump cuts Scores of scientists conducting vital research across a range of fields from infectious diseases, robotics and education to computer science and the climate crisis have responded to a Guardian online callout to share their experiences about the impact of the Trump administration's cuts to science funding. Many said they had already had funding slashed or programs terminated, while others feared that cuts were inevitable and were beginning to search for alternative work, either overseas or outside science. So far the cuts have led to a 60% reduction in Johnson's team, and fear is mounting over the future of 30 years of climate data and expertise as communities across the US are battered by increasingly destructive extreme weather events. Read the full story Trump fossil-fuel push setting back green progress decades, critics warn Ever since Donald Trump began his second presidency, he has used an 'invented' national energy emergency to help justify expanding oil, gas and coal while slashing green energy – despite years of scientific evidence that burning fossil fuels has contributed significantly to climate change, say scholars and watchdogs. It's an agenda that in only its first six months has put back environmental progress by decades, they say. Read the full story What else happened today: Trump said he would help Afghans detained in the United Arab Emirates for years after fleeing their country when the US pulled out and the Taliban took power. Polls released on Sunday showed falling support among Americans for Trump's hardline measures against illegal immigration, as the Republican president celebrated six months back in power. Polls from CNN and CBS show Trump has lost majority support for his deportation approach. A growing group of African Americans are ditching corporate big-box retail stores that rolled back their DEI programs and instead are shopping at small, minority- and women-owned businesses they believe value their dollars more. Catching up? Here's what happened on 19 July.

ICE Chief Doubles Down On Arresting Undocumented People With No Criminal History
ICE Chief Doubles Down On Arresting Undocumented People With No Criminal History

Yahoo

time20 minutes ago

  • Yahoo

ICE Chief Doubles Down On Arresting Undocumented People With No Criminal History

President Donald Trump once promised to focus on the 'worst of the worst' as he sought to ramp up immigrant deportations, but a recent interview from his acting ICE chief underscored just how far the administration has departed from that vow. ICE is doubling down on arresting undocumented immigrants without criminal histories, Todd Lyons, the acting head of the federal body, told CBS's Camilo Montoya-Galvez in an exclusive interview. 'Under this administration, we have opened up the whole aperture of the immigration portfolio,' he said. 'If we encounter someone that isn't here in the country legally, we will take them into custody.' That approach marks a sharp break from the policies of the Biden administration, which directed agents to apprehend undocumented immigrants with criminal backgrounds, those who posed a national security threat and those who had entered the U.S more recently, CBS notes. It's also counter to claims that the Trump administration once made about focusing on those with serious criminal records, and prompted sharp blowback as ICE agents have targeted everyone from a high school student driving to sports practice to immigrants attending routine court hearings. Of the roughly 100,000 deportations ICE has documented between January 1 and June 24, about 70,000 involved a person with a criminal conviction, a CBS review of internal government data found. And just a small fraction of those who faced criminal convictions did so for violent offenses, Montoya-Galvez noted. (Living in the U.S. without documentation is a civil offense and not a criminal offense, Vanity Fair notes.) 'We can't look at it just based on violence,' Lyons said in the CBS interview. A July Axios review also determined that noncriminal ICE arrests increased in June, and that 'people without criminal charges or convictions made up an average of 47% of daily ICE arrests' in the early portion of that month. Lyons claimed in the interview that deporting immigrants who are 'the worst of the worst' was still a chief priority for the administration, and DHS did not immediately respond to a request for comment. Lyons also outlined other ways that ICE will ramp up enforcement as it receives a staggering funding infusion from Republicans' recent tax bill, which will make it the highest funded federal law enforcement agency in the U.S. The agency will continue workplace raids, despite the concerns that have been raised about racial profiling and the trauma they've caused for immigrant communities. It will also penalize companies that hire undocumented immigrants, he said. 'We're focusing on these American companies that are actually exploiting these laborers,' Lyons said. Lyons noted, too, that agents will continue to wear masks during enforcement actions, due to concerns for their privacy and personal safety, a move that has garnered criticism for shielding officers from accountability and inspiring fear in immigrants who are approached by them. 'I'm not a proponent of the masks; however, if that's a tool that the men and women of ICE use to keep themselves and their families safe, then I'll allow it,' he said. Such moves come as the president has reportedly set a goal of a million deportations by the end of this year, one which Lyons said was 'possible' to achieve as ICE's sweeping and controversial tactics continue unabated. 'We hear a lot about the administration deporting the worst of the worst. And as far as we can tell from all available data up to this point, the data has not really supported that,' Austin Kocher, a professor at Syracuse University, told ABC News in July. Related... Volunteers Flock To Support Migrants Targeted By ICE At Immigration Courts Army Veteran And U.S. Citizen Arrested In California Immigration Raid Old Clip Of Stephen Miller Praising Torture Resurface Amid Aggressive Immigration Enforcement

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store